1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Impact of COVID-19 on Global Clinical Trial Outsourcing
Market
5.
Voice of Customer
5.1.
Reasons for Clinical Trial Outsourcing
5.2.
Clinical Trial Outsourcing, By Region
5.3.
Clinical Trial Outsourcing, By Clinical Trial Phase
5.4.
Clinical Trial Outsourcing, By Therapeutic Area
5.5.
Brand Awareness
6. Global Clinical
Trial Outsourcing Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase
3, Phase 4)
6.2.2.
By Therapeutic Area (Oncology, Hematology, Central Nervous
System, Cardiovascular/Metabolic, Respiratory, Infectious Diseases, Immunology,
Rare Diseases, Medical Devices, Others)
6.2.3.
By End User (Biotechnology & Pharmaceutical
Companies, Medical Device Companies, Academic & Research Institutions)
6.2.4.
By Company (2021)
6.2.5. By
Region
6.3.
Product Market Map
7. North America Clinical
Trial Outsourcing Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Clinical Trial Phase
7.2.2.
By Therapeutic Area
7.2.3.
By End User
7.2.4.
By Country
7.3.
North America: Country Analysis
7.3.1.
United States Clinical Trial Outsourcing
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Clinical Trial Phase
7.3.1.2.2.
By Therapeutic Area
7.3.1.2.3.
By End User
7.3.2.
Mexico Clinical Trial Outsourcing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Clinical Trial Phase
7.3.2.2.2.
By Therapeutic Area
7.3.2.2.3.
By End User
7.3.3.
Canada Clinical Trial Outsourcing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Clinical Trial Phase
7.3.3.2.2.
By Therapeutic Area
7.3.3.2.3.
By End User
8. Europe Clinical
Trial Outsourcing Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Clinical Trial Phase
8.2.2.
By Therapeutic Area
8.2.3.
By End User
8.2.4.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Clinical Trial Outsourcing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Clinical Trial Phase
8.3.1.2.2.
By Therapeutic Area
8.3.1.2.3.
By End User
8.3.2.
Germany Clinical Trial Outsourcing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Clinical Trial Phase
8.3.2.2.2.
By Therapeutic Area
8.3.2.2.3.
By End User
8.3.3.
United Kingdom Clinical Trial Outsourcing
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Clinical Trial Phase
8.3.3.2.2.
By Therapeutic Area
8.3.3.2.3.
By End User
8.3.4.
Italy Clinical Trial Outsourcing Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Clinical Trial Phase
8.3.4.2.2.
By Therapeutic Area
8.3.4.2.3.
By End User
8.3.5.
Spain Clinical Trial Outsourcing Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Clinical Trial Phase
8.3.5.2.2.
By Therapeutic Area
8.3.5.2.3.
By End User
9. Asia-Pacific Clinical
Trial Outsourcing Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Clinical Trial Phase
9.2.2.
By Therapeutic Area
9.2.3.
By End User
9.2.4.
By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1.
China Clinical Trial Outsourcing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Clinical Trial Phase
9.3.1.2.2.
By Therapeutic Area
9.3.1.2.3.
By End User
9.3.2.
India Clinical Trial Outsourcing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Clinical Trial Phase
9.3.2.2.2.
By Therapeutic Area
9.3.2.2.3.
By End User
9.3.3.
South Korea Clinical Trial Outsourcing
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Clinical Trial Phase
9.3.3.2.2.
By Therapeutic Area
9.3.3.2.3.
By End User
9.3.4.
Japan Clinical Trial Outsourcing Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Clinical Trial Phase
9.3.4.2.2.
By Therapeutic Area
9.3.4.2.3.
By End User
9.3.5.
Australia Clinical Trial Outsourcing Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Clinical Trial Phase
9.3.5.2.2.
By Therapeutic Area
9.3.5.2.3.
By End User
10. South America Clinical
Trial Outsourcing Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Clinical Trial Phase
10.2.2.
By Therapeutic Area
10.2.3.
By End User
10.2.4.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Clinical Trial Outsourcing Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Clinical Trial Phase
10.3.1.2.2.
By Therapeutic Area
10.3.1.2.3.
By End User
10.3.2.
Argentina Clinical Trial Outsourcing Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Clinical Trial Phase
10.3.2.2.2.
By Therapeutic Area
10.3.2.2.3.
By End User
10.3.3.
Colombia Clinical Trial Outsourcing Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Clinical Trial Phase
10.3.3.2.2.
By Therapeutic Area
10.3.3.2.3.
By End User
11. Middle East and
Africa Clinical Trial Outsourcing Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Clinical Trial Phase
11.2.2.
By Therapeutic Area
11.2.3.
By End User
11.2.4.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Clinical Trial Outsourcing
Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Clinical Trial Phase
11.3.1.2.2.
By Therapeutic Area
11.3.1.2.3.
By End User
11.3.2.
Saudi Arabia Clinical Trial Outsourcing
Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Clinical Trial Phase
11.3.2.2.2.
By Therapeutic Area
11.3.2.2.3.
By End User
11.3.3.
UAE Clinical Trial Outsourcing Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Clinical Trial Phase
11.3.3.2.2.
By Therapeutic Area
11.3.3.2.3.
By End User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
ICON plc. (PRA Health Sciences)
14.2.
PAREXEL International Corp.
14.3.
Thermo Fischer Scientific, Inc. (Pharmaceutical Product Development,
LLC.)
14.4.
Sygnature Discovery Limited
14.5.
WuXi AppTec Co., Ltd.
14.6.
Laboratory Corporation of America Holdings
14.7.
Jubilant Biosys Limited
14.8.
Charles River Laboratories International, Inc.
14.9.
Albany Molecular Research, Inc.
14.10.
Syneos Health Inc
15. Strategic Recommendations